Licensing

To access Zera® assembler peptides and StorPro® organelles

Zera® assembler peptides are adaptable to most of the standard protein production platforms based on non-microbial eukaryotic cells and animal/plant transgenics. Over 30 research groups and companies are already enhancing their own systems and products with Zera® assembler peptides and StorPro® designed storage organelles. Contact Zera® to learn about the commercial license policy. Zera® is also available for research purposes under two licensing formats:

In-depth Trial
Partner evaluates Zera® technology in its own laboratories, using its preferred protein-production platform
Right to express and evaluate any number of products
Customized duration depending on production platform
Option for Commercial License on products registered during Trial
Material and Technical Support included
Basic Downstream Process Development Support included

One-shot Trial
Partner uses Zera® technology in-house to test compatibility with its own protein-production platform
Expression rights are limited to a fluorescent protein reporter
Option for Evaluation License
Customized duration depending on production platform
Material and technical Support included



Fields of interest
ERA Biotech develops and deploys the Zera® technology as a standard productivity tool for the manufacture of protein-based products for pharmaceutical, industrial, energy and health/nutrition applications.

ERA Biotech welcomes co-development partners with select product concept opportunities.


For more information :
François Arcand, farcand |at| erabiotech.com
François Devesa, fdevesa |at| erabiotech.com